top of page

Home
About us
MPN Community
For Patients
Groups
Members
For Professionals
Professionals
For Patients
Groups
Members
For Professionals
Professionals
MPN Resources
News
You and MPN by MPN RF
Events & Webinars
Videos
News
You and MPN by MPN RF
Events & Webinars
Videos
Wellbeing
Dietary
Dietary
Contact

Everything you need to know about MPNs!

We sorted the articles into categories to help you out finding the right information.

All Posts
What are MPNs?
Diagnosed with MPN?
Living with MPNs
Women
Teens & Children
Events
MPN News
MPN Stories
Clinical Trials
Wellbeing

All Posts

The potential of Tasquinimod in the treatment of advanced Myeloproliferative Neoplasms (MPNs): A look into the future

The potential of Tasquinimod in the treatment of advanced Myeloproliferative Neoplasms (MPNs): A look into the future

The potential of Tasquinimod in the treatment of advanced Myeloproliferative Neoplasms (MPNs): A look into the future

Feb 5, 2024

Strategies for Managing Anxiety in MPN Patients

Strategies for Managing Anxiety in MPN Patients

Strategies for Managing Anxiety in MPN Patients

Living with MPNs

Feb 5, 2024

World Cancer Day and MPNs

World Cancer Day and MPNs

World Cancer Day and MPNs

Feb 2, 2024

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Feb 1, 2024

Summary of MPN Educational Roundtables: The Importance of Mental Health

Summary of MPN Educational Roundtables: The Importance of Mental Health

Summary of MPN Educational Roundtables: The Importance of Mental Health

Jan 30, 2024

EMA Approves Momelotinib: A Breakthrough for Myelofibrosis Patients

EMA Approves Momelotinib: A Breakthrough for Myelofibrosis Patients

EMA Approves Momelotinib: A Breakthrough for Myelofibrosis Patients

Jan 29, 2024

Rusfertide's REVIVE Study Highlights 2-Year Efficacy in Polycythemia Vera (PV)

Rusfertide's REVIVE Study Highlights 2-Year Efficacy in Polycythemia Vera (PV)

Rusfertide's REVIVE Study Highlights 2-Year Efficacy in Polycythemia Vera (PV)

Clinical Trials

Jan 18, 2024

Navigating Life After a Recent MPN Diagnosis: Finding Support and Understanding

Navigating Life After a Recent MPN Diagnosis: Finding Support and Understanding

Navigating Life After a Recent MPN Diagnosis: Finding Support and Understanding

Diagnosed with MPN?

Jan 10, 2024

Webinar: MPN Educational Roundtables (24th - 26th January)

Webinar: MPN Educational Roundtables (24th - 26th January)

Webinar: MPN Educational Roundtables (24th - 26th January)

Jan 9, 2024

Newsletter

Sign up to receive the latest news about our activities and MPN news.

Email*

Contact

Avenida Josep Tarradellas 157, 5o 2a - Barcelona, 08029 - España

Email:
info@gmpnsf.org

Quick links

Terms and conditions

CONTENT TRANSLATION DISCLAIMER

Please note that this website uses AI to automatically translate its content into other languages to help people better understand the material we originally published in English. While we have made every effort to ensure the accuracy of the translation, there may be some errors or inaccuracies. We apologize for any mistakes and suggest referring to the original English text for the most accurate information.

MEDICAL DISCLAIMER

The information on this website is provided for informational purposes only and is not intended to replace the advice given by your physician or other healthcare professional. You should not use the information on this website to diagnose or treat any health problem or disease, or to prescribe any medication or other treatment.
Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Nothing contained on this website is intended for medical diagnosis or treatment. It should not be used in place of advice from your physician or another qualified healthcare provider. If you have any healthcare-related questions, call or consult your physician or another qualified healthcare provider immediately.
Always consult with your physician or another qualified healthcare provider before starting any new treatment, diet, or fitness program.

This website does not recommend self-management of health problems. The information obtained through the use of this website is not comprehensive and does not cover all diseases, ailments, physical conditions, or their treatments. If you have any healthcare-related questions, call or consult your physician or another qualified healthcare provider immediately. Never disregard medical advice or delay seeking it because of something you have read here.

Home
About us
MPN Community
- For Patients
  - Groups
  - Members
- For Professionals
  - Professionals
MPN Resources
Wellbeing
- Dietary
Contact

bottom of page